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a b s t r a c t
Background: An outbreak of surgical site infection (SSI) due to environmental mycobacteria
(EMB) occurred in a hospital in Eastern India.
Method: A quality improvement project (QIP) was undertaken to analyze the causes and
prevent further outbreak. Step (1) Proof of the need: Four patients who had undergone
pacemaker implantation consecutively during a 10-day period developed SSI. Step (2)
Diagnostic journey: Since all patients developed SSI within 2 months of implantation, a
common source of infection was likely. Atypical mycobacteria (AMB) were grown from
surgical sites as well as from the surface of operation table, image intensiﬁer, and lead
aprons. It was a rapid growing variety that lacked pigment, a characteristic of EMB with
pathogenic potential. The EMB was ﬁnally traced to its source, the overhead water tank. Step
(3) Remedial journey: By thorough cleaning of the water tank and enriching its chlorine
content, the EMB was eliminated from its source. Step (4) Holding the gains: Protocol for
cleaning the water tank once in 3 months was made. A checklist was prepared to ensure
compliance to asepsis protocol in the operation theater. In the ensuing 5 years, the infection
did not recur.
Result: The bacteria that caused SSI were identiﬁed as EMB that grew in the water tank and
contaminated the operation room. It could be eliminated by appropriate measures.
Interpretation: Water is a potential reservoir for EMB. Use of the term 'environmental
mycobacteria' instead of 'atypical mycobacteria' will generate awareness about contami-
nation as the cause of SSI.
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Surgical site infection (SSI) after permanent pacemaker
implantation is very low (less than 2% of the annual implanta-
tions in most centers) and Staphylococcus epidermidis is the
commonest pathogen.1 We report an outbreak of pacemaker
pocket infection due to environmental mycobacteria (EMB) and
the corrective measures that were implemented.
2. Material
In our pacemaker implantation unit, the incidence of re-do
surgery for deep SSI was 0.83% and occurred in 13 of the 1380
pacemakers implanted from 1982 to 2008.2 They were sporadic
and S. epidermidis was the culprit organism. But in the year
2009, of the 146 pacemaker implantation procedures, ﬁve
procedures in four patients were complicated by SSI (3.42% of
the annual implantations). Initial swabs from the infected
sites neither showed any microorganism in Gram stain nor
any bacterial growth on culture. Purulent discharge persisted
despite antibiotics and microbiology tests were repeated. Acid
fast bacilli were found on Ziehl-Nielson staining, which grewTable 1 – Profile of SSI due to EMB in four patients (AMB – atypi












































Healthy wound on Stitch remorapidly in Lowenstein-Jensen medium and were reported as
'atypical mycobacteria (AMB)'. The outbreak occurred in all
four patients who underwent pacemaker implantation con-
secutively over a 10-day period from 21st March to 1st April
2009. The clinical presentation was that of SSI within 6 weeks
of surgery with redness, purulent discharge, and non-healing
operation site without any systemic feature like fever (Table 1).
Only the 4th patient responded to antibiotics and wound
dressing, while the rest required removal of the pacemakers,
debridement, and reimplantation on the contralateral side
after sterilization with ethylene oxide. The 2nd patient
underwent reimplantation in the same operation theater
(OT), before the bacteria were eliminated from their environ-
mental source, which led to recurrent infection in the 2nd site
as well. Thus, in four patients, there were ﬁve instances of SSI.
3. Method and results
The OT was closed in mid-June 2009 and a quality improve-
ment project (QIP) was initiated. QIP is a tool to solve a problem
through measures in cross-functional areas and is conducted
in four steps.3cal mycobacteria; EMB – environmental mycobacteria; QIP –
t).
Course of SSI, treatment and outcome
Abscess noted on 14th April 2009, 3 weeks after Sx. AMB
in aspirated pus. ATT for 2 months – no response.
Explanation and debridement on 26th June 2009. Wound
healed well.
A new Relia RESR01 was implanted in contra lateral side
on 2nd August 2009 in the same OT. Healed well. Ok till
March 2014
val.
Redness and discharge from 20th post-op day leading to
sinus. Vancomycin > linezolid. Pus swab – no bacteria
initially, then AMB isolated.
ATT > Oﬂoxacin > Ciproﬂaxacin. Explantation and
debridement on 1st June 2009. Re-implanted on the
opposite site on 4th June 2009 in the same OT. Developed
early SSI with persistent discharge, despite ATT,
Oﬂoxacin > Trimethoprim/sulphamethoxazole. EMB
suspected. QIP undertaken. Explantation and
debridement on 7th August 2009. A new pacemaker,
Adapta ADSR03 & lead were implanted on the ﬁrst side on
14th August 2009 in the same OT. Healthy wound on
stitch removal. Ok till March 2014
Persistent slight ooze up to 29th April 2009. Pus swab sent
– AMB isolated. Treated with linezolid, ciproﬂoxacin;
alternate day cleaning and dressing. Satisfactory wound
healing by end May 2009, followed for 2 months post-op.
Ok till March 2014
val.
Swelling at op site after 6 weeks > discharging sinus. AMB
isolated from pus. ATT for 4 months-sinus persisted.
Explanation and debridement on 14th November 2009. A
new Regency 2406L was implanted on 25th November
2009. Healthy wound on stitch removal. Ok on follow-up
till March 2014
Table 2 – Observation before the QIP and result/measures after the QIP.
Parameters Observation before QIP Results/measures after QIP
EMB in swabs from OT Present Absent
EMB in water tank Present Absent
Chlorine content of water 0.1–0.2 ppm 1.0 ppm (during the remedial journey)
Protocol for cleaning lead aprons Absent Weekly wash with soap and water
Cleaning of overhead water tank Once a year Once in 3 months
Cleaning of AHU ﬁlters Weekly with water Weekly with soap and water
Surveillance of OT asepsis Not documented Surveillance check list with assigned responsibility for
compliance was incorporated as quality document
Microbiology test for mycobacteria
in specimens from SSI
Not routinely done. Ziehl-Nielson stain
was done in the cases in Table 1, since
Gram stain was negative and no fungi
were seen. Non-pigmented rapidly
growing mycobacteria were seen on
culture but antibiogram was not done
Ziehl-Neilson stain to be routinely done from SSI
specimens. If acid-fast rods are detected, culture in
Lowenstein-Jensen medium to be carried out.
Antibiogram to be tested for the mycobacteria grown
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(i) SSI in four consecutive patients who underwent a
pacemaker implantation consecutively over a 10-day
period.
(ii) A rise in SSI rate from 0.83% (1983–2008) to 3.42% in 2009.
Step 2: Diagnostic journey and observations.
Root cause analysis: AMB isolated from the swabs taken from
patients who underwent consecutive pacemaker implanta-
tions pointed to a common source for the bacteria.
A process ﬂowchart of all the activities involved in
pacemaker implantation was made. The method of steriliza-
tion of surgical instruments and surgical protocol in the OT
were reviewed and found to be as per standard recommenda-
tions.4 Swabs for microbiology testing were taken from the
walls and ﬂoor of the OT, operation table, C-arm of the image
intensiﬁer, racks kept in the OT, lead aprons, lead collars, and
surgical instruments. AMB was isolated from three objects –
operation table, C-arm, and lead aprons. A commonality in the
contaminated objects was searched by brainstorming and the
source was thought to be water or dust. Tap water was used to
wipe the operation table and C-arm before and after every
procedure. Lead aprons that were worn before scrubbing
tended to get splashed with water. There was no protocol to
clean the lead aprons. The AMB grew within 3–5 days and
lacked pigmentation, which is the characteristic of a group of
EMB with pathogenic potential.5 The group includes Mycobac-
terium fortuitum and Mycobacterium chelonei/abscessus, known to
cause SSI.6 Since the usual source of EMB is water and soil, we
sent a sample of the tap water and took more swabs from ﬂoor,
foot wear, and from the outlet of central air conditioning duct.5Table 3 – Surveillance checklist for maintaining asepsis in OT.
Activity Fr
Cleaning of OT Daily 
Bleaching powder in wash areas, drains Weekly
Washing of lead aprons and collars Weekly
Washing of OT Weekly
Swabs for microbiology test Fortnig
Cleaning of ﬁlter at AC outlet Weekly
Cleaning AHU ﬁlters Weekly
Cleaning of water tank Once in
Super chlorination Once inNone of those samples grew mycobacteria, but it was isolated
from a sample collected from the bottom of the overhead
water tank. The next action was to ﬁnd the reason for
mycobacterial growth in the water tank. Chlorine content of
the tap water was checked and found to be 0.1 ppm. At the
source of water supply, chlorine was added @1 ppm, which
was sufﬁcient to prevent most of the water-borne diseases.
Step 3: Remedial journey and result. Municipal water stored
in tanks could harbor EMB, since the chlorine content
diminished progressively from source to end point.7–9 For
eradicating EMB, a higher concentration of chlorine is
recommended.4,10 The water tank was thoroughly cleaned
and hypochlorite solution was added to initially achieve
chlorine content of 2 ppm. Thereafter, a chlorine pump was
installed for constant dosing from a container of hypochlo-
rite solution, to maintain a concentration of 1 ppm.4,10 Lead
aprons and collars were thoroughly cleaned with soap and
water. The OT table and C-arm were wiped clean with soap
solution. A quality circle of the staff was formed to
implement 5 S in the OT (sorting, shining, sweeping,
systematizing, and self-discipline). Even though ﬁlters of
the air-handling units were washed weekly with a forceful
jet of water, washing with soap water was recommended as
a general hygiene measure (Table 2). Effectiveness of the
corrective measures was veriﬁed weekly, by checking for
EMB in swabs and water samples. The density of EMB
growth reduced, and after 4 weeks, none of the samples
grew the organism. The OT became functional in early
August 2009, after 6 weeks. None of the subsequent 56
pacemaker implantations in the year 2009 developed SSIequency Accountability
Assigned staff nurse
 – on Sundays Assigned cleaning staff
 – on Fridays Assigned staff nurse
 – on Sundays Assigned cleaning staff
htly Sister in charge
 Air conditioning staff
 Air conditioning staff
 3 months Water management section
 6 months Water management section
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Step 4: Holding the gains. A surveillance checklist was
incorporated to ensure cleaning of the OT premises,
fortnightly microbiology test, 3-monthly cleaning of the
water tank, and ﬁlters of the air-handling unit (Table 3). A
laboratory protocol was made to subject all specimens of
pus/discharge from SSI to Gram stain, Ziehl-Neilson stain,
and routine culture initially. If the tests are negative or if
acid fast bacilli are detected, culture in Lowenstein-Jensen
medium is to be carried out and antibiogram tested for the
mycobacteria grown. After the QIP over the next 5 years
(from August 2009 to March 2014), 628 pacemaker implan-
tation procedures were carried out. There were two isolated
cases of superﬁcial SSI in the year 2012 and 2014 caused by
S. epidermidis, but EMB infection did not recur. Our
experience was shared with another hospital in an
outlocation that experienced similar type of SSI in an OT.
The QIP methodology was implemented with an equally
successful result.
4. Discussion
Infection after a clean elective surgical procedure like perma-
nent pacemaker implantation is expected to be low; and SSI
after the implantation of an expensive cardiac device causes
much anguish to the patient and the implanting physician.
Superﬁcial SSI due to common skin organisms is often easy to
treat and prevent by reinforcing aseptic surgical norms. This
series of four patients with SSI due to an uncommon organism
such as EMB posed a great challenge to treat the individual
cases and trace the organism to its source. Even after getting
the report of AMB, we did not have an immediate clear solution
to the problem. Therefore, we applied the step-by-step
approach of a QIP. Our cross-functional team comprised of
clinicians, nurses, technicians, microbiologist, water manage-
ment staff, air conditioning staff, and administrators who
analyzed and interacted.
Pacemaker pocket infection due to EMB is very rare.11,12
Nosocomial SSI caused by EMB has been reported in
cardiothoracic, laparoscopic, plastic surgery, and joint re-
placement units.13–16 There was considerable delay in attrib-
uting the infection to EMB in our series as well as in other
reports due to its rarity, low index of clinical suspicion, and
varied time to manifest that ranged from immediately after
surgery to as long as 2 years. Systemic features like fever are
known to be remarkably absent. The ﬁrst clue for SSI caused by
the unusual pathogen was frank purulent discharge from
which no bacteria could be isolated from routine tests and the
lack of response to anti-Staphylococcal antibiotics. It should
prompt Ziehl-Nielson staining of pus to identify mycobacteria
as rods. Mycobacterium tuberculosis and Mycobacterium leprae are
well known to cause human infection. The rest more than 50
species of mycobacteria are collectively known by various
names – AMB/non-tuberculous mycobacteria/mycobacteria
other than tuberculosis.5 The broad term AMB includes species
with four types of infective potential: pathogenic to animals,
opportunistic infections in humans, non-infective sapro-
phytes, and saprophytes with pathogenic potential. Thesaprophytes with pathogenic potential grow in water and
dust and cause SSI due to contamination. Outbreaks of SSI due
to contamination of endoscopes, cardioplegia solution, and
methylene blue have been reported.13–16 Person to person
transmission of EMB infection does not occur. Based on the
rate of growth in culture medium and pigmentation, Runyun
classiﬁed AMB into four groups.17 Groups 1, 11, and 111 are
slow-growing bacteria that take more than 2 weeks to grow in
culture medium.
I. Photochromogens – produce pigment when exposed to
light, e.g. Mycobacterium kansasii, Mycobacterium marinum,
and Mycobacterium simiae
II. Scotochromogens – get pigmented in darkness, e.g.
Mycobacterium scrofulaceum, and Mycobacterium szulgai
III. Nonchromogens – do not produce pigment, e.g. opportu-
nistic pathogens including Mycobacterium avium complex,
Mycobacterium ulcerans, Mycobacterium xenopi, etc.
IV. Rapid growing mycobacteria (RGM) – grow within 3–5 days,
e.g. M. fortuitum and M. chelonae/abscessus.
Several species of EMB that are ubiquitous in nature belong
to the group of RGM. The colonies of non-infective saprophytes
are pigmented and the colonies of potentially pathogenic
species like M. fortuitum and M. chelonae/abscessus lack
pigment. Identiﬁcation of the type of mycobacteria by the
above-mentioned broad guidelines should be possible in any
health care service with basic laboratory facilities. Accurate
species differentiation would require polymerase chain reac-
tion-restriction enzyme analysis (PCR-REA).
The EMB are resistant to the usual anti-tuberculous drugs;
therefore species differentiation and antibiotic sensitivity are
essential for treatment.5,18 There are reports for successful
treatment with oﬂoxacin and various combinations of
clarithromycin, amikacin, sulfonamides, ciproﬂoxacin, doxy-
cycline, linezolid, etc. for prolonged periods ranging from 3
weeks to 3 months or even longer.5,6,18,19 The third patient in
our series responded to frequent wound dressing and empiric
treatment with linezolid and ciproﬂoxacin for 6 weeks. Deep
SSI would require an aggressive surgical approach by wide
excision, debridement, and removal of the implant.11,12,19 In
the ﬁrst and fourth patients, the infected pacemakers were
removed and new pacemakers were implanted on the
contralateral side with good outcome. However, in the second
patient, due to ﬁnancial constraints, we resorted to reimplan-
tation of the same pacemaker in the contralateral side after
ETO sterilization. The infection recurred on the contralateral
side also and the infection subsided only after removal of the
pacemaker and debridement. By then, the ﬁrst side had healed
and a new pacemaker was implanted there. There are several
reports of reusing pacemakers explanted after death with
satisfactory results. Reuse of pacemaker/device removed due
to infection is not to be practiced since it carries a high risk of
harboring deep SSI in the pectoral muscle bed and loss of site
for implantation. In our patient, we could use the original side,
but we do not recommend reuse of pacemakers explanted due
to infection. The usual methods of OT sterilization and
the amount of chlorine in municipal water supply are not
sufﬁcient to eradicate mycobacteria.4,5 We could eliminate the
mycobacteria by cleaning the tank and chlorine enrichment
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nance, superchlorination once in 6 months is recommended.20
It involves enriching the chlorine content in water tanks to
10 ppm and allowing the water to run through the pipelines for
about 5–6 h so that bioﬁlm that tends to form in the interphase
between water and solid surfaces can be eliminated/pre-
vented. Bioﬁlm is a potential site for harboring organisms that
can cause nosocomial infection. Superchlorination should be
conducted at a time when water consumption is the least;
Sundays from 2.00 PM to 7.00 PM. Care should be taken to avoid
pipelines for hemodialysis units and to provide alternate
source of drinking water during the 6 h.
Through this QIP, we could trace the outbreak to contami-
nation of the OT with rapid growing non-pigmented EMB from
the water tank. We speculate that persistent mycobacteria in
the water source and an increase in the bacterial load in a short
period led to the outbreak in patients who underwent
consecutive pacemaker implantation during that time. Liter-
ature search on the subject gave us a direction to curtail the
outbreak through structured protocol and surveillance.
5. Conclusion
Water-borne nosocomial infection is an emerging global
problem that needs to be recognized and addressed at local
level.6 Microbiology report using the nomenclature of EMB,
rather than AMB, will generate awareness to suspect the
infection as a consequence of contamination. Infection with
EMB does not respond to the usual anti-tuberculous drugs and
antibiotic use must be guided by antibiogram. Prolonged
course of treatment and even wound debridement may be
required to eliminate the infection. As a preventive measure,
we recommend 3-monthly cleaning of water tanks connected
to operation theaters and 6-monthly superchlorination of
water tanks and pipelines.
6. Limitation
Due to lack of facility for RT-PCR (real time PCR for the
detection of mRNA), we could not identify the speciﬁc type of
EMB.
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